Baran, A.; Stepaniuk, A.; Hermanowicz, J.M.; Sieklucka, B.; Pawlak, K.; Pawlak, D.; Flisiak, I.
Serum Semaphorin Alterations in Psoriasis: Links to Metabolic Status Rather than Disease Severity. Metabolites 2026, 16, 190.
https://doi.org/10.3390/metabo16030190
AMA Style
Baran A, Stepaniuk A, Hermanowicz JM, Sieklucka B, Pawlak K, Pawlak D, Flisiak I.
Serum Semaphorin Alterations in Psoriasis: Links to Metabolic Status Rather than Disease Severity. Metabolites. 2026; 16(3):190.
https://doi.org/10.3390/metabo16030190
Chicago/Turabian Style
Baran, Anna, Anna Stepaniuk, Justyna Magdalena Hermanowicz, Beata Sieklucka, Krystyna Pawlak, Dariusz Pawlak, and Iwona Flisiak.
2026. "Serum Semaphorin Alterations in Psoriasis: Links to Metabolic Status Rather than Disease Severity" Metabolites 16, no. 3: 190.
https://doi.org/10.3390/metabo16030190
APA Style
Baran, A., Stepaniuk, A., Hermanowicz, J. M., Sieklucka, B., Pawlak, K., Pawlak, D., & Flisiak, I.
(2026). Serum Semaphorin Alterations in Psoriasis: Links to Metabolic Status Rather than Disease Severity. Metabolites, 16(3), 190.
https://doi.org/10.3390/metabo16030190
